Has Susan Berger received payments from drug or device companies?

Yes. Drug and device makers reported $4,773 in general payments to Susan Berger across 147 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Susan Berger did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Susan Berger come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Susan Berger

Psychiatric/Mental Health · Springfield, OHNPI 1063804631

Payments from drug & device makers

$4,773in general payments, 2019–2025

Across 147 payments — averaging $32.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Alkermes, Inc.$792
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$530
Otsuka America Pharmaceutical, Inc.$508
Lilly USA, LLC$290
Teva Pharmaceuticals USA, Inc.$267
plus $1K from 14 others

What the payments were for

Food & beverage$4,72499%
Education$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	44	$1,192
Alkermes, Inc.	19	$792
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	13	$530
Otsuka America Pharmaceutical, Inc.	11	$508
Lilly USA, LLC	9	$290
Teva Pharmaceuticals USA, Inc.	4	$267
Axsome Therapeutics, Inc.	6	$244
Novo Nordisk	12	$217
Tempus AI, Inc	2	$124
Idorsia Pharmaceuticals US Inc	3	$100
Neurocrine Biosciences, Inc.	3	$97
Pfizer	5	$93
AstraZeneca	2	$79
Almatica Pharma LLC	3	$61
Lundbeck LLC	3	$41
Indivior Inc.	2	$31
Bayer	2	$31
Johnson & Johnson	2	$30
Exact Sciences	1	$25
Abbott	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,773 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
AristadaAripiprazole Lauroxil	17	$55,475
CaplytaLumateperone Tosylate	11	$17,962
Lurasidone Hcl	31	$12,962
TrintellixVortioxetine Hydrobromide	15	$7,184
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	47	$3,049
Carbamazepine ErCarbamazepine	50	$2,393
Aripiprazole	38	$1,289
Benztropine Mesylate	22	$569
Quetiapine Fumarate	38	$542
Lamotrigine	69	$529
Duloxetine Hcl	15	$496
Buspirone Hcl	47	$473
Hydroxyzine Hcl	21	$453
Quetiapine Fumarate ErQuetiapine Fumarate	16	$396
Mirtazapine	13	$373

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Alkermes, Inc.Aristada	$792	$55,47517 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$530	$17,96211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Springfield

Crystal TravisJackson$333K
Kristina RoweIronton$253K
Patricia SparksPortsmouth$210K
Mary HallWarren$195K
Kassandra KornbauCanfield$170K
Terri PopovitzCincinnati$161K
Steven MatesDayton$121K
Robert ParsonsYoungstown$119K
Chriscia BaneChillicothe$115K
Rachael McLaughlinMaple Heights$114K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →